PoDBAY efficacy estimation

2021-09-20

This document accompanies the “A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data.” publication. It describes the application of PoDBAY package on the PoDBAY efficacy estimation examples using data from clinical trial(s).

The goal of PoDBAY efficacy estimation analysis is to:

• Estimate PoDBAY efficacy with its confidence intervals
• Estimate $$p_{max}$$, $$et_{50}$$ and $$\gamma$$ parameters of the PoD curve point estimate with its confidence intervals
• Plot the PoD curve with its confidence intervals

We describe two scenarios of application in PoDBAY efficacy estimation:

• General case presented in the main body of the publication - We have full titer information about diseased and non-diseased cases from the clinical trial. See examples of inactivated influenza vaccines and zoster vaccine for further details.
• Non-diseased immunogenicity sample case presented in the supplementary material of the publication - We have full titer information about diseased subjects but only partial titer information about non-diseased subjects in the immunogenicity sample. See example of dengue vaccine for further details.

PoDBAY efficacy introduction

PoDBAY efficacy is estimated in two subsequent steps as described in the publication, section Methods.

1. PoD-titer relationship estimation - using Trial A subject level data.
• diseased and non-diseased subject level data are required
2. PoDBAY efficacy estimation - using estimated PoD curve (step 1) and Trial B population summary data.
• vaccinated and control population summary statistics (N, mean, sd) are required

Notes:

• Trial A should be large enough and have enough disease cases to estimate the PoD-titer relationship
• Trial A and Trial B data could come from the same clinical trial.
Trial A and Trial B data could come from different phases of development. For example Trial A - phase2 and Trial B - phase 3.

1. PoD-titer relationship estimation - Trial A

PoD curve is estimated (point estimate together with confidence intervals) in three steps - further details can be found in the publication, section Methods.

1. Titers of all diseased and all non-diseased subjects are used for estimation of PoD curve parameters. Parameter estimates $$p_{max}^$$, $$et_{50}^$$ and $$\gamma^$$ are obtained.

2. Titers of all diseased and all non-diseased subjects are put together and bootstrapped. For each individual titer a probability of disease is calculated using the PoD curve with parameter values $$p_{max}^$$, $$et_{50}^$$ and $$\gamma^$$. New disease status is assigned to each titer based on the probability of disease.

3. Titers of all new diseased and all new non-diseased subjects are used for re-estimation of PoD curve parameters. Parameter estimates $$p_{max}^{}$$, $$et_{50}^{}$$ and $$\gamma^{}$$ are obtained.

Data preparation

Diseased and non-diseased subject level data are required. We’ll use PoDBAY::diseased and PoDBAY::nondiseased mock-up data. Both datasets contain population summary statistics (N, mean, sd) and individual subject level data (log2 titers, disease status (DS))

Only the individual subject level data (log2 titers, DS) are used for the PoD curve estimation as described above.

library(PoDBAY)
data(diseased)
data(nondiseased)
str(diseased)
#> Reference class 'Population' [package ".GlobalEnv"] with 8 fields
#>  $N : int 35 #>$ mean               : num 3.83
#>  $stdDev : num 1.66 #>$ unknownDistribution: logi FALSE
#>  $UDFunction :function () #>$ titers             : Named num [1:35] 5.59 6.07 2.43 5.84 6.29 ...
#>   ..- attr(*, "names")= chr [1:35] "vacc" "vacc" "vacc" "vacc" ...
#>  $PoDs : num(0) #>$ diseaseStatus      : logi [1:35] TRUE TRUE TRUE TRUE TRUE TRUE ...
#>  and 24 methods, of which 10 are  possibly relevant:
#>    assignPoD, getDiseasedCount, getDiseasedTiters, getNondiseasedCount,
#>    getNondiseasedTiters, getTiters, getUnknown, initialize, popFun, popX
str(nondiseased)
#> Reference class 'Population' [package ".GlobalEnv"] with 8 fields
#>  $N : int 1965 #>$ mean               : num 6.01
#>  $stdDev : num 2.3 #>$ unknownDistribution: logi FALSE
#>  $UDFunction :function () #>$ titers             : Named num [1:1965] 5.75 7.37 5.33 10.19 7.66 ...
#>   ..- attr(*, "names")= chr [1:1965] "vacc" "vacc" "vacc" "vacc" ...
#>  $PoDs : num(0) #>$ diseaseStatus      : logi [1:1965] FALSE FALSE FALSE FALSE FALSE FALSE ...
#>  and 24 methods, of which 10 are  possibly relevant:
#>    assignPoD, getDiseasedCount, getDiseasedTiters, getNondiseasedCount,
#>    getNondiseasedTiters, getTiters, getUnknown, initialize, popFun, popX

Note: To convert your data in to the population class object use generatePopulation() function from PoDBAY package. See vignette vignette("population", package = "PoDBAY") for further details.

PoD curve estimation

Once we have our data prepared function PoDParamEstimation is used to estimate PoD curve parameters in three steps as described above. For more details about the usage of the function see examples in ?PoDParamEstimation().

estimatedParameters <- PoDParamEstimation(diseasedTiters = diseased$titers, nondiseasedTiters = nondiseased$titers,
nondiseasedGenerationCount = nondiseased$N, repeatCount = 50) Step 1: $$p_{max}^$$, $$et_{50}^$$ and $$\gamma^$$ Results corresponding to the first step of estimation of PoD-titer relationship can be obtained via estimatedParameters$resultsPriorReset.

#> # A tibble: 50 x 3
#>      pmax slope  et50
#>     <dbl> <dbl> <dbl>
#>  1 0.0343  28.5  6.05
#>  2 0.0343  28.5  6.05
#>  3 0.0343  28.5  6.05
#>  4 0.0343  28.5  6.05
#>  5 0.0343  28.5  6.05
#>  6 0.0343  28.5  6.05
#>  7 0.0343  28.5  6.05
#>  8 0.0343  28.5  6.05
#>  9 0.0343  28.5  6.05
#> 10 0.0343  28.5  6.05
#> # … with 40 more rows

Note that parameter estimates are the same for every repeatCount iteration. This is according to our expectations as the same diseased and non-diseased cases are used in every iteration in step 1 of this example.

Step 2: Bootstrap and re-assignment of disease status Titers of all diseased and all non-diseased subjects are put together and bootstrapped. For each individual titer a probability of disease is calculated using the PoD curve with parameter values $$p_{max}^$$, $$et_{50}^$$ and $$\gamma^$$. New disease status is assigned to each titer based on the probability of disease.

Step 3: $$p^{}_{max}$$, $$et^{}_{50}$$ and $$\gamma^{}$$

PoDParametersCI <- PoDParamsCI(estimatedParameters$results, ci = 0.95) unlist(PoDParametersCI) #> PmaxCILow PmaxCIHigh Et50CILow Et50CIHigh SlopeCILow SlopeCIHigh #> 0.02425859 0.04787302 5.53529308 6.36748061 12.86874466 34.17583340 PoD curve plot Using PoD curve point estimate and results from step 3 - estimatedParameters PoD curve can be plotted. titers <- seq(from = 0, to = 15, by = 0.01) PoDCurve <- PoDCurvePlot(titers, estimatedParameters, ci = 0.95) PoDCurve 2. PoDBAY efficacy estimation - Trial B PoDBAY Efficacy (point estimate together with confidence intervals) is estimated - further details can be found in the publication, section Methods. 1. Efficacy point estimate is obtained using: • The point estimate of PoD curve PoDParamsPointEst from step 1 PoD-titer relationship estimation - Trial A • Vaccinated and control population summary statistics - mean, sd. 2. Vaccinated and control population mean is jittered to account for uncertainty in the population mean. Using the N and standard deviation of the population we sample the mean titer of the vaccinated and control group: $$mean = m + N(0, \frac{sd}{\sqrt{n}})$$ 3. Efficacy set $$e^{}$$ is estimated using: • PoD curve parameter values $$p_{max}^{}$$, $$et_{50}^{}$$ and $$\gamma^{}$$ from estimatedParameters$results from step 1 PoD-titer relationship estimation - Trial A
• Vaccinated and control population jittered means (step 2) and standard deviations
4. Efficacy confidence intervals are estimated using quantiles of estimated efficacy set $$e^{}$$ from step 3

Data preparation

Vaccinated and control population summary statistics (N, mean, sd) are required. We’ll use PoDBAY::vaccinated and PoDBAY::control mock-up data. Both datasets contain population summary statistics (N, mean, sd) and individual subject level log2 titers.

Only the population summary statistics (N, mean, sd) data are used for the PoDBAY efficacy estimation as described above.

data(vaccinated)
data(control)
str(vaccinated)
#> Reference class 'Population' [package ".GlobalEnv"] with 8 fields
#>  $N : num 1000 #>$ mean               : num 7
#>  $stdDev : num 2 #>$ unknownDistribution: logi FALSE
#>  $UDFunction :function () #>$ titers             : num [1:1000] 5.75 7.37 5.33 10.19 7.66 ...
#>  $PoDs : num [1:1000] 0.0137 0.00311 0.01952 0.00034 0.00241 ... #>$ diseaseStatus      : logi [1:1000] FALSE FALSE FALSE FALSE FALSE FALSE ...
#>  and 24 methods, of which 10 are  possibly relevant:
#>    assignPoD, getDiseasedCount, getDiseasedTiters, getNondiseasedCount,
#>    getNondiseasedTiters, getTiters, getUnknown, initialize, popFun, popX
str(control)
#> Reference class 'Population' [package ".GlobalEnv"] with 8 fields
#>  $N : num 1000 #>$ mean               : num 5
#>  $stdDev : num 2 #>$ unknownDistribution: logi FALSE
#>  $UDFunction :function () #>$ titers             : num [1:1000] 7.27 7.22 3.26 5.42 5.14 ...
#>  $PoDs : num [1:1000] 0.00339 0.00354 0.04762 0.0181 0.02261 ... #>$ diseaseStatus      : logi [1:1000] FALSE FALSE FALSE FALSE FALSE FALSE ...
#>  and 24 methods, of which 10 are  possibly relevant:
#>    assignPoD, getDiseasedCount, getDiseasedTiters, getNondiseasedCount,
#>    getNondiseasedTiters, getTiters, getUnknown, initialize, popFun, popX

Note: To convert your data in to the population class object use generatePopulation() function from PoDBAY package. See vignette vignette("population", package = "PoDBAY") for further details.

Efficacy point estimate

Once we have our data prepared function efficacyComputation is used to estimate Efficacy point estimate as described above in step 1.

means <- list("vaccinated" = vaccinated$mean, "control" = control$mean)

standardDeviations  <- list("vaccinated" = vaccinated$stdDev, "control" = control$stdDev)

EfficacyPointEst <- efficacyComputation(PoDParamsPointEst,
means,
standardDeviations)
EfficacyPointEst
#> [1] 0.5383405

Efficacy set $$e^{}$$

Jittering of population mean from step 2 by drawing from sampling distribution is done inside of PoDBAYEfficacy function. Efficacy set is estimated as described above in step 3

efficacySet <- PoDBAYEfficacy(estimatedParameters$results, vaccinated, control) Efficacy confidence intervals Confidence intervals (95% level of significance) of PoDBAY efficacy are obtained as described above in step 4. CI <- EfficacyCI(efficacySet, ci = 0.95) unlist(CI) #> mean median CILow CIHigh #> 0.5429269 0.5492815 0.4767003 0.6106386 PoDBAY efficacy - output summary Analysis provides following results: • PoDBAY efficacy point estimate with its confidence intervals (80%, 90% and 95% level of significance) • $$p_{max}$$, $$et_{50}$$ and $$\gamma$$ parameters of the PoD curve point estimate with its confidence intervals (80%, 90% and 95% level of significance) • Plot of the PoD curve with its confidence intervals result <- list( EfficacyPointEst = EfficacyPointEst, efficacyCI = unlist(CI), PoDParamsPointEst = PoDParamsPointEst, PoDParametersCI = unlist(PoDParametersCI), PoDCurve = PoDCurve ) result #>$EfficacyPointEst
#> [1] 0.5383405
#>
#> $efficacyCI #> mean median CILow CIHigh #> 0.5429269 0.5492815 0.4767003 0.6106386 #> #>$PoDParamsPointEst
#>            pmax    slope     et50
#> pmax 0.03430108 28.51659 6.051696
#>
#> $PoDParametersCI #> PmaxCILow PmaxCIHigh Et50CILow Et50CIHigh SlopeCILow SlopeCIHigh #> 0.02425859 0.04787302 5.53529308 6.36748061 12.86874466 34.17583340 #> #>$PoDCurve

Appendix

In a frequent case when serum samples at baseline and after vaccination are collected and assayed only in a subset of subjects (“immunogenicity sample/ subset”) and the assay value of titer is obtained also for all disease cases at the same time points, the general method for PoD curve estimation described above can be extended. Further details can be found in the publication Appendix A.

1. PoD-titer relationship estimation

PoD curve is estimated (point estimate together with confidence intervals) in three steps.

1. Titers of all non-diseased subjects are generated by random sampling with replacement from immunogenicity subset.

2. Titers of all diseased and all generated non-diseased subjects (generated in step 1) are used for estimation of PoD curve parameters. Parameter estimates $$p_{max}^$$, $$et_{50}^$$ and $$\gamma^$$ are obtained.

3. Titers of all diseased and all non-diseased subjects are put together and bootstrapped. For each individual titer a probability of disease is calculated using the PoD curve with parameter values $$p_{max}^$$, $$et_{50}^$$ and $$\gamma^$$. New disease status is assigned to each titer based on the probability of disease.

4. New immunogenicity subset is selected from all new non-diseased, such that the ratio of all diseased versus non-diseased in immunogenicity subset in new data match the ratio in original data.

5. Titers of all new non-diseased subjects are generated by random sampling with replacement from new immunogenicity subset.

6. Titers of all new diseased and all new generated non-diseased subjects (generated in step 5) are used for re-estimation of PoD curve parameters. Parameter estimates $$p_{max}^{}$$, $$et_{50}^{}$$ and $$\gamma^{}$$ are obtained.

Non-diseased immunogenicity sample

Assume hypothetical case where we have clinical trial data of 2,000 subjects from which only 200 subjects’ plasma samples are collected and examined in the immunogenicity study. Further, out of these 2,000 we identify 35 disease cases to which we measure titers from the same time point. In the end we have titer information about 200 subjects from the immunogenicity study and 35 diseased subjects.

Population # subjects (N)
Whole Trial
All subjects 2,000
Diseased 35
Non-diseased 1,965
Measured titers
Diseased 35
Immunogenicity sample 200

Note that in the immunogenicity sample the disease status is unknown as the sample is created before the clinical study. However, vaccination status is known.

In our example the steps would be following:

1. Titers of all non-diseased subjects (N = 1,965) are generated by random sampling with replacement from immunogenicity subset (N = 200).

2. Titers of all diseased (N = 35) and all generated non-diseased (N = 1,965) subjects are used for estimation of PoD curve parameters.

3. Titers of all diseased (N = 35) and all generated non-diseased (N = 1,965) subjects are put together and bootstrapped (N = 2,000).

4. New immunogenicity subset is selected from all new non-diseased ($$N^$$ = 2000 - X), such that the ratio of all new diseased ($$N^$$ = X) versus new non-diseased in immunogenicity subset in new data match the ratio in original data (ratio = 200:35).

Population # subjects ($$N^$$)
New diseased $$X$$
New non-diseased $$2000 - X$$
New Immunogenicity sample $$X * \frac{200}{35}$$
1. Titers of all new non-diseased subjects are generated by random sampling with replacement from new immunogenicity subset ($$N^ = X * \frac{200}{35}$$)

2. Titers of all new diseased ($$N^ = X$$) and all new generated non-diseased subjects ($$N^ = 2000 - X$$) are used for second estimation of PoD curve parameters.

Data preparation

Diseased and non-diseased subject level data are required. We’ll use PoDBAY::diseased and PoDBAY::nondiseased mock-up data. Both datasets contain population summary statistics (N, mean, sd) and individual subject level data (log2 titers, diseases status (DS))

Only the individual subject level data (log2 titers, DS) are used for the PoD curve estimation as described above.

We create the immunogenicity sample from our mock-up data as described above - We start with the titer information about 200 subjects from the immunogenicity study and 35 diseased subjects.

data(diseased)
data(nondiseased)

# Immunogenicity sample created
ImmunogenicitySample <- BlindSampling(diseased, nondiseased, method = list(name = "Fixed", value = 200))
nondiseasedImmunogenicitySample <- ImmunogenicitySample$ImmunogenicityNondiseased str(diseased) #> Reference class 'Population' [package ".GlobalEnv"] with 8 fields #>$ N                  : int 35
#>  $mean : num 3.83 #>$ stdDev             : num 1.66
#>  $unknownDistribution: logi FALSE #>$ UDFunction         :function ()
#>  $titers : Named num [1:35] 5.59 6.07 2.43 5.84 6.29 ... #> ..- attr(*, "names")= chr [1:35] "vacc" "vacc" "vacc" "vacc" ... #>$ PoDs               : num(0)
#>  $diseaseStatus : logi [1:35] TRUE TRUE TRUE TRUE TRUE TRUE ... #> and 24 methods, of which 10 are possibly relevant: #> assignPoD, getDiseasedCount, getDiseasedTiters, getNondiseasedCount, #> getNondiseasedTiters, getTiters, getUnknown, initialize, popFun, popX str(nondiseasedImmunogenicitySample) #> Reference class 'Population' [package "PoDBAY"] with 8 fields #>$ N                  : int 196
#>  $mean : num 5.93 #>$ stdDev             : num 2.45
#>  $unknownDistribution: logi FALSE #>$ UDFunction         :function ()
#>  $titers : Named num [1:196] 7.7 8.59 8.15 9.1 11.89 ... #> ..- attr(*, "names")= chr [1:196] "vacc" "vacc" "vacc" "vacc" ... #>$ PoDs               : num(0)
#>  $diseaseStatus : logi [1:196] FALSE FALSE FALSE FALSE FALSE FALSE ... #> and 24 methods, of which 10 are possibly relevant: #> assignPoD, getDiseasedCount, getDiseasedTiters, getNondiseasedCount, #> getNondiseasedTiters, getTiters, getUnknown, initialize, popFun, popX PoD curve estimation Note: From now on the analysis and used functions are the same as in general case. Only the input variable change from unifected to NondiseasedImmunogenicitySample. The nondiseasedGenerationCount remains the same as the total number of nondiseased remains the same in the whole trial. Once we have our data prepared, function PoDParamEstimation is used to estimate PoD curve parameters in six steps as described above. For more details about the usage of the function see examples in ?PoDParamEstimation(). estimatedParametersAP <- PoDParamEstimation(diseasedTiters = diseased$titers,
nondiseasedTiters = nondiseasedImmunogenicitySample$titers, nondiseasedGenerationCount = nondiseased$N,
repeatCount = 50)

Step 1: $$p_{max}^$$, $$et_{50}^$$ and $$\gamma^$$

Results corresponding to the first step of Estimation of PoD-titer relationship can be obtained via estimatedParametersAP$resultsPriorReset. #> # A tibble: 49 x 3 #> pmax slope et50 #> <dbl> <dbl> <dbl> #> 1 0.0324 34.3 6.05 #> 2 0.0318 34.3 6.08 #> 3 0.0322 34.3 6.08 #> 4 0.0324 34.3 6.08 #> 5 0.0315 34.3 6.10 #> 6 0.0316 34.3 6.07 #> 7 0.0325 34.3 6.09 #> 8 0.0322 34.3 6.10 #> 9 0.0316 34.3 6.09 #> 10 0.0323 34.3 6.07 #> # … with 39 more rows Note that parameter estimates are now different for each repeatCount iteration. This is according to our expectations as titers of all non-diseased subjects are generated by random sampling with replacement from immunogenicity subset in every iteration in step 1 of this example. Step 2: Data generation and re-assignment of disease status Step 3: $$p^{}_{max}$$, $$et^{}_{50}$$ and $$\gamma^{}$$ Results corresponding to the sixth step of estimation of PoD-titer relationship can be obtained via estimatedParametersAP$results.

#> # A tibble: 49 x 3
#>      pmax slope  et50
#>     <dbl> <dbl> <dbl>
#>  1 0.0347 39.8   5.99
#>  2 0.0231 16.0   5.89
#>  3 0.0351 21.4   5.77
#>  4 0.0419 12.1   5.46
#>  5 0.0301 39.8   6.04
#>  6 0.0483  4.59  3.92
#>  7 0.0393 43.7   5.94
#>  8 0.0386 36.8   6.06
#>  9 0.0314 40.5   6.35
#> 10 0.0263 32.7   6.00
#> # … with 39 more rows

Non-parametric bootstrap described in step 3 together with creation of new immunogenicity sample in step 4-5is applied inside the function.

PoD curve point estimate

Parameters of PoD curve point estimate representing the PoD-titer relationship are estimated using results from ‘step 1’ - estimatedParametersAP$resultsPriorReset. PoDParamsPointEst <- PoDParamPointEstimation(estimatedParametersAP$resultsPriorReset)
PoDParamsPointEst
#>            pmax    slope     et50
#> pmax 0.03218197 33.85696 6.085131

PoD curve confidence intervals

Confidence intervals (80%, 90% and 95% level of significance) of PoD curve parameters are calculated using results from ‘step 6’ - estimatedParametersAP$results. PoDParametersCI <- PoDParamsCI(estimatedParametersAP$results)
unlist(PoDParametersCI)
#>   PmaxCILow  PmaxCIHigh   Et50CILow  Et50CIHigh  SlopeCILow SlopeCIHigh
#>  0.02140353  0.04420208  5.36664708  6.54030103  6.63482304 43.47149473

PoD curve plot

Using PoD curve point estimate and results from step 6 - estimatedParametersAP PoD curve can be plotted.

titers <- seq(from = 0, to = 15, by = 0.01)

PoDCurve <- PoDCurvePlot(titers,
estimatedParametersAP,
ci = 0.95)

PoDCurve

2. PoDBAY efficacy estimation - Trial B

There are two possible situations:

• Trial A = Trial B. Therefore both trials are the same and we have immunogenicity subset information only for both trials as described above.
• Only change would be in the data availability as for Trial B we do not have the titer information from the whole trial (N = 2,000) but only from the immunogenicity sample (N = 200). However, the PoDBAY efficacy estimation approach and analysis steps remain the same as in general case.
• Trial A - we have immunogenicity subset as described above. Trial B is the same as in general case.
• No change in the PoDBAY efficacy estimation approach. Analysis steps remain the same as in general case.

We will describe the approach in the situation where Trial A = Trial B.

Data preparation

As stated above the only difference is in the data availability. The fact that vaccinated and control population summary statistics (N, mean, sd) are required remains the same. Therefore, we calculate summary statistics for both populations using immunogenicity subset data - created in the PoD-titer relationship estimation step.

# Immunogenicity sample - vaccinated
str(ImmunogenicitySample$ImmunogenicityVaccinated) #> Reference class 'Population' [package "PoDBAY"] with 8 fields #>$ N                  : int 97
#>  $mean : num 7.03 #>$ stdDev             : num 2.34
#>  $unknownDistribution: logi FALSE #>$ UDFunction         :function ()
#>  $titers : Named num [1:97] 7.7 8.59 8.15 9.1 11.89 ... #> ..- attr(*, "names")= chr [1:97] "vacc_FALSE" "vacc_FALSE" "vacc_FALSE" "vacc_FALSE" ... #>$ PoDs               : num(0)
#>  $diseaseStatus : logi [1:97] FALSE FALSE FALSE FALSE FALSE FALSE ... #> and 24 methods, of which 10 are possibly relevant: #> assignPoD, getDiseasedCount, getDiseasedTiters, getNondiseasedCount, #> getNondiseasedTiters, getTiters, getUnknown, initialize, popFun, popX # Immunogenicity sample - control str(ImmunogenicitySample$ImmunogenicityControl)
#> Reference class 'Population' [package "PoDBAY"] with 8 fields
#>  $N : int 103 #>$ mean               : num 4.73
#>  $stdDev : num 2.13 #>$ unknownDistribution: logi FALSE
#>  $UDFunction :function () #>$ titers             : Named num [1:103] 2.17 4.53 2.51 6.08 4.22 ...
#>   ..- attr(*, "names")= chr [1:103] "control_FALSE" "control_FALSE" "control_FALSE" "control_FALSE" ...
#>  $PoDs : num(0) #>$ diseaseStatus      : logi [1:103] FALSE FALSE FALSE FALSE FALSE FALSE ...
#>  and 24 methods, of which 10 are  possibly relevant:
#>    assignPoD, getDiseasedCount, getDiseasedTiters, getNondiseasedCount,
#>    getNondiseasedTiters, getTiters, getUnknown, initialize, popFun, popX

Efficacy point estimate

means <- list("vaccinated" = ImmunogenicitySample$ImmunogenicityVaccinated$mean,
"control" = ImmunogenicitySample$ImmunogenicityControl$mean)

standardDeviations  <- list("vaccinated" = ImmunogenicitySample$ImmunogenicityVaccinated$stdDev,
"control" = ImmunogenicitySample$ImmunogenicityControl$stdDev)

EfficacyPointEst <- efficacyComputation(PoDParamsPointEst,
means,
standardDeviations)
EfficacyPointEst
#> [1] 0.5298448

Efficacy set $$e^{}$$

efficacySet <- PoDBAYEfficacy(estimatedParametersAP$results, ImmunogenicitySample$ImmunogenicityVaccinated,
ImmunogenicitySample$ImmunogenicityControl) Efficacy confidence intervals CI <- EfficacyCICoverage(efficacySet) unlist(CI) #> mean median CILow95 CIHigh95 CILow90 CIHigh90 CILow80 CIHigh80 #> 0.5375903 0.5419903 0.4432219 0.6231131 0.4527044 0.6106371 0.4608834 0.5999084 PoDBAY efficacy - output summary Analysis provides following results: • PoDBAY efficacy point estimate with its confidence intervals (80%, 90% and 95% level of significance) • $$p_{max}$$, $$et_{50}$$ and $$\gamma$$ parameters of the PoD curve point estimate with its confidence intervals (80%, 90% and 95% level of significance) • Plot of the PoD curve with its confidence intervals result <- list( EfficacyPointEst = EfficacyPointEst, efficacyCI = unlist(CI), PoDParamsPointEst = PoDParamsPointEst, PoDParametersCI = unlist(PoDParametersCI), PoDCurve = PoDCurve ) result #>$EfficacyPointEst
#> [1] 0.5298448
#>
#> $efficacyCI #> mean median CILow95 CIHigh95 CILow90 CIHigh90 CILow80 CIHigh80 #> 0.5375903 0.5419903 0.4432219 0.6231131 0.4527044 0.6106371 0.4608834 0.5999084 #> #>$PoDParamsPointEst
#>            pmax    slope     et50
#> pmax 0.03218197 33.85696 6.085131
#>
#> $PoDParametersCI #> PmaxCILow PmaxCIHigh Et50CILow Et50CIHigh SlopeCILow SlopeCIHigh #> 0.02140353 0.04420208 5.36664708 6.54030103 6.63482304 43.47149473 #> #>$PoDCurve`